Tsuneo Shimokawa

4PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Aug 07, 2023
Association of PD-L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC.

Yusuke Hamakawa, Yoko Agemi, Aya Shiba

|Aug 18, 2022
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.

Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi

|Dec 15, 2020
Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer.

Tsuneo Shimokawa, Kazuhiko Yamada, Hiroshi Tanaka

Pageof 1

Frequent Collaborators

2 joint publications

Yuichi Takiguchi

2 joint publications

Katsuhiko Naoki

1 joint publications

Yuri Taniguchi

1 joint publications

Toshihiro Misumi